This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessArticle
Spherical Coordinate System for Dyslipoproteinemia Phenotyping and Risk Prediction
by
Justine Cole
Justine Cole 1,*
,
Maureen Sampson
Maureen Sampson 2
and
Alan T. Remaley
Alan T. Remaley 1
1
Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
2
Clinical Center, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD 20892, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(21), 7557; https://doi.org/10.3390/jcm14217557 (registering DOI)
Submission received: 28 August 2025
/
Revised: 9 October 2025
/
Accepted: 20 October 2025
/
Published: 24 October 2025
Abstract
Background/Objectives: The factors contributing to residual atherosclerotic cardiovascular disease (ASCVD) risk in individuals are not fully understood, but knowledge of the specific type of dyslipoproteinemia may help further refine risk assessment. We developed a novel phenotyping and risk assessment system that may be applied automatically using standard lipid panel parameters. Methods: NHANES data collected from 37,056 individuals during 1999–2018 were used to develop a three-dimensional dyslipidemia phenotype classification system. ARIC data from 14,632 individuals were used to train and validate the risk model. Three-dimensional Cartesian coordinates were converted to spherical coordinates, which were used as features in a logistic regression model that provides a probability of ASCVD. UK Biobank data from 354,344 individuals were used to further validate and test the model. Results: Nine lipidemia phenotypes were defined based on the concentrations of HDLC, non-HDLC and TG. These phenotypes were related to the prevalence of metabolic syndrome, pooled cohort equation (PCE) score and ASCVD-free survival. A logistic regression model including age, sex and the spherical coordinates of the phenotype provided a composite risk score with predictive accuracy comparable to that of the PCEs. Conclusions: We provided an example of how a multidimensional coordinate system may be used to define a novel lipoprotein phenotyping system to examine disease associations. When applied to an ASCVD risk model, the composite spherical coordinate risk marker, which can be fully automated, provided an F1 performance score almost as good as the PCEs, which requires other risk factors besides lipids.
Share and Cite
MDPI and ACS Style
Cole, J.; Sampson, M.; Remaley, A.T.
Spherical Coordinate System for Dyslipoproteinemia Phenotyping and Risk Prediction. J. Clin. Med. 2025, 14, 7557.
https://doi.org/10.3390/jcm14217557
AMA Style
Cole J, Sampson M, Remaley AT.
Spherical Coordinate System for Dyslipoproteinemia Phenotyping and Risk Prediction. Journal of Clinical Medicine. 2025; 14(21):7557.
https://doi.org/10.3390/jcm14217557
Chicago/Turabian Style
Cole, Justine, Maureen Sampson, and Alan T. Remaley.
2025. "Spherical Coordinate System for Dyslipoproteinemia Phenotyping and Risk Prediction" Journal of Clinical Medicine 14, no. 21: 7557.
https://doi.org/10.3390/jcm14217557
APA Style
Cole, J., Sampson, M., & Remaley, A. T.
(2025). Spherical Coordinate System for Dyslipoproteinemia Phenotyping and Risk Prediction. Journal of Clinical Medicine, 14(21), 7557.
https://doi.org/10.3390/jcm14217557
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.